Skip to main content
54°
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about NBIX
Recent news which mentions NBIX
< Previous
1
2
3
4
5
6
Next >
What Analysts Are Saying About Neurocrine Biosciences Stock
December 20, 2024
Tickers
NBIX
Tags
Market News
Benzinga
BZI/AAR
From
Benzinga
Neurocrine's Drug Gains FDA Nod As First Targeted Treatment For Certain Type Of Inherited Disorder, Analyst Highlights Blockbuster Potential
December 16, 2024
Tickers
CRNX
NBIX
NEWS
Tags
Health Care
Large Cap
Benzinga
From
Benzinga
Screening For Black Friday Bargains In The Stock Market
December 03, 2024
Tickers
EXPE
NBIX
NVDA
SUPN
Tags
NBIX
Expert Ideas
Market News
From
Benzinga
AbbVie's Schizophrenia Failure Disappoints But Analysts Show Confidence In Immunology Portfolio
November 12, 2024
Tickers
ABBV
BMY
NBIX
NEWS
Tags
Benzinga
Large Cap
Briefs
From
Benzinga
In-Depth Examination Of 20 Analyst Recommendations For Neurocrine Biosciences
October 29, 2024
Tickers
NBIX
Tags
Market News
Analyst Ratings
Benzinga
From
Benzinga
Critical Insights From Neurocrine Biosciences Analyst Ratings: What You Need To Know
October 04, 2024
Tickers
NBIX
Tags
BZI/AAR
Benzinga
Analyst Ratings
From
Benzinga
"Rule Breaker Investing" Market Cap Game Show: Throwdowns & Long-Term Wins
September 30, 2024
Tickers
AMD
HEI
KFRC
LOW
Tags
TDG
SYNA
HEI
From
Motley Fool
Neurocrine Shifts Focus To New Schizophrenia Treatment After Luvadaxistat Trial Misses Endpoint
September 13, 2024
Tickers
NBIX
NEWS
Tags
Health Care
Briefs
Biotech
From
Benzinga
Decoding 19 Analyst Evaluations For Neurocrine Biosciences
September 09, 2024
Tickers
NBIX
Tags
Benzinga
BZI/AAR
Analyst Ratings
From
Benzinga
Intel, Moderna And Dollar General Were Among Top 10 Large Cap Losers In August: Are The Others In Your Portfolio?
September 08, 2024
Tickers
CRL
DG
GFI
INTC
Tags
Stories That Matter
Top Stories
DG
From
Benzinga
Dollar General, Temu Parent PDD And Super Micro Computer Are Among Top 10 Large Cap Losers Last Week (Aug 25-Aug 31): Are The Others In Your Portfolio?
September 02, 2024
Tickers
COIN
DG
DLTR
MSTR
Tags
News
DG
NBIX
From
Benzinga
Why Neurocrine Biosciences Stock Was Tumbling This Week
August 30, 2024
Tickers
NBIX
Tags
Recent Press Releases
Market News
NBIX
From
Motley Fool
Neurocrine Biosciences' Lower Dose Data Puts Its Schizophrenia Candidate In The Game, Analyst Upgrades Stock
August 29, 2024
Tickers
NBIX
NEWS
Tags
Biotech
Upgrades
Briefs
From
Benzinga
NVIDIA To Rally Over 31%? Here Are 10 Top Analyst Forecasts For Thursday
August 29, 2024
Tickers
CRM
CRWD
EQNR
HPQ
Tags
NVDA
Benzinga
SPOT
From
Benzinga
Nasdaq Down Over 1%; Foot Locker Shares Tumble After Q2 Results
August 28, 2024
Tickers
ATPC
AVAV
BOF
FL
Tags
Benzinga
BOF
ATPC
From
Benzinga
As Regulators Gear Up To Decide On Bristol Myers' Schizophrenia Treatment, Neurocrine Biosciences' Data Disappoints Investors
August 28, 2024
Tickers
ABBV
BMY
NBIX
NEWS
Tags
Health Care
Trading Ideas
Movers
From
Benzinga
US Stocks Mixed; JM Smucker Slashes Annual Guidance
August 28, 2024
Tickers
ATPC
BOF
BSLK
NBIX
Tags
Market News
Commodities
NBIX
From
Benzinga
Regulators Expected To Approve Innovative Schizophrenia Treatment From Bristol Myers, Karuna
August 27, 2024
Tickers
ABBV
BMY
LLY
NBIX
Tags
Stories That Matter
Top Stories
BMY
From
Benzinga
Evaluating Neurocrine Biosciences: Insights From 15 Financial Analysts
August 19, 2024
Tickers
NBIX
Tags
Market News
BZI/AAR
Benzinga
From
Benzinga
9 Health Care Stocks Whale Activity In Today's Session
August 13, 2024
Tickers
BPMC
EW
EXAS
IBRX
Tags
SAVA
EXAS
BPMC
From
Benzinga
A Closer Look at 7 Analyst Recommendations For Neurocrine Biosciences
August 01, 2024
Tickers
NBIX
Tags
NBIX
Analyst Ratings
Benzinga
From
Benzinga
Cracking The Code: Understanding Analyst Reviews For Neurocrine Biosciences
July 10, 2024
Tickers
NBIX
Tags
NBIX
Market News
Analyst Ratings
From
Benzinga
7 Breakthrough Biotech Stocks for a Shot of Portfolio Adrenaline
June 17, 2024
Tickers
AMGN
BLUE
BMY
GILD
Tags
GILD
RARE
NBIX
From
InvestorPlace
Key Takeaways From Neurocrine Biosciences Analyst Ratings
May 28, 2024
Tickers
NBIX
Tags
NBIX
Market News
BZI/AAR
From
Benzinga
Cracking The Code: Understanding Analyst Reviews For Neurocrine Biosciences
May 01, 2024
Tickers
NBIX
Tags
NBIX
Market News
Analyst Ratings
From
Benzinga
NBIX Stock Earnings: Neurocrine Biosciences Beats EPS, Beats Revenue for Q1 2024
May 01, 2024
Tickers
NBIX
Tags
NASDAQ:NBIX
NBIX
Earnings Reports
From
InvestorPlace
3 Red-Hot Biotech Rockets Blasting Off in 2024
April 24, 2024
Tickers
GERN
NBIX
VKTX
Tags
Stocks to Buy
NBIX
GERN
From
InvestorPlace
Neurocrine Biosciences Says Treatment Can Alleviate Several Symptoms Associated With Depressive Disorder
April 23, 2024
Tickers
NBIX
NEWS
TAK
Tags
NBIX
News
why it's moving
From
Benzinga
Where Neurocrine Biosciences Stands With Analysts
April 10, 2024
Tickers
NBIX
Tags
NBIX
Market News
Benzinga
From
Benzinga
Analyst Bullish On Gene Therapy-Focused Voyager Therapeutics Sees Best In Class Potential For Its Neurogenetic Medicine Platform
March 19, 2024
Tickers
AZN
NBIX
NEWS
NVS
Tags
Equities
Price Target
General
From
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
